What modified Finnegan score typically indicates the need for medication?

The modified Finnegan scoring system is used to assess withdrawal symptoms in infants exposed to opioids or other substances during pregnancy. A score of 9 and above is generally considered the threshold indicating that the infant is experiencing significant withdrawal symptoms and may require pharmacological intervention to alleviate these symptoms.

This score encompasses various signs, including neurological, gastrointestinal, and autonomic dysregulation symptoms. When the cumulative score reaches 9 or higher, it reflects a more severe degree of withdrawal that can lead to complications. Therefore, pharmacologic treatment is typically recommended to manage the withdrawal symptoms effectively and support the infant's overall health during the transition period.

A score below this threshold usually indicates milder symptoms that may not necessitate medication, leaning instead towards supportive care measures. As such, understanding the significance of the modified Finnegan score in clinical practice is essential for proper management and treatment of neonatal withdrawal syndrome.